About the Book Discusses three major classes of asthma therapies-bronchodilators, antiinflammatories, and antiallergics-as well as potential new therapeutic approaches!<br>This comprehensive volume addresses the latest treatment strategies for asthma, keying in on the genetics and molecular biology of asthma and pointing the way toward new, commercially viable therapies.<br>Presents the most up-to-date information available on the genetics, epidemiology, pathology, pharmacology, and pulmonology of asthma.<br>Written by more than 20 leading international experts, New and Exploratory Therapeutic Agents for Asthma <li>explores asthma both as incidence of dysfunctional airway smooth muscle and as a disorder of the immune system <br> </li><li>examines the role of monoclonal antibodies in allergy and asthma <br> </li><li>describes functions and pharmacokinetic profiles of bronchodilator 2 agonists, anticholinergics, and inhaled glucocorticosteroids <br> </li><li>investigates the controversy of different types of asthma <br> </li><li>illustrates the connections between clinical symptoms and the immunopathology of eosinophilic inflammation <br> </li><li>assesses prospects for the development of a successful oral anti-inflammatory therapy, an immunomodulator that lowers antigen-specific IgE, an anticytokine compound, and an agent that safely combines bronchospasmolytic and anti-inflammatory properties <br> </li><li>reviews the impact of the recent introduction of antileukotriene agents, clinical findings with PAF antagonists, and selective antimuscarinics <br> </li><li>evaluates the relationship between improvements in laboratory results and clinical effectiveness <br> </li><li>and more!<br>Containing over 2000 bibliographic citations and a concise introduction for each chapter, New and Exploratory Therapeutic Agents for Asthma is indispensable for pulmonologists, pediatricians, physiologists, immunologists, allergists, pharmaceutical industry scientists, primary care physicians, and medical s</li>